July 22, 2025 02:00 ET | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…
AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…
July 21, 2025 03:30 ET | Source: Orion Oyj ORION CORPORATION PRESS RELEASE 21 JULY 2025 at 10:30 EEST Darolutamide…
BENGALURU, India, July 17, 2025 /PRNewswire/ -- India is witnessing an alarming public health crisis with heart attacks increasingly striking…
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination…
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS,…
CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with…
LEXINGTON, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Constant Therapy today announced a first-in-state collaboration with New York-based Burke Rehabilitation…
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /PRNewswire/ -- Berlin…
Clinical study in Scientific Reports shows Bridge Capture™ detects key mutations from blood samples in metastatic colorectal cancer patients TURKU,…